BeiGene · 10 hours ago
Summer Internship: US Field Medical Excellence Intern (Remote)
BeiGene is a company dedicated to fighting cancer, and they are seeking a Summer Internship: US Field Medical Excellence Intern. This internship will involve supporting special projects related to the Field Medical/MSL role and engaging with colleagues across relevant departments to understand and execute project plans.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Work closely with US Field Medical Excellence lead to prepare, implement and execute project plan(s) for assigned special project(s)
Engage with BeiGene colleagues across relevant departments and levels to understand needs and opportunities specific to assigned project(s) and lead project team to complete assigned project(s) while ensuring timeliness and broad participation
Provide regular status updates on assigned project(s) to US Field Medical Excellence lead
Receive exposure to / work collaboratively with BeiGene colleagues in Field Medical roles, along with other roles within US Medical Affairs
Qualification
Required
Actively pursuing advanced degree (PharmD, PhD, etc.) in a scientific field
Adept in PowerPoint, Excel and similar programs
Interest in the Field Medical (aka “Medical Science Liaison, MSL”) role
Collaborative, driven, results-oriented, good communication and organizational skills
Benefits
Medical
Dental
Vision
401(k)
FSA/HSA
Life Insurance
Paid Time Off
Wellness
Company
BeiGene
BeiGene is a global oncology company.
H1B Sponsorship
BeiGene has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (32)
2023 (39)
2022 (40)
2021 (28)
2020 (16)
Funding
Current Stage
Public CompanyTotal Funding
$6.79BKey Investors
Hillhouse InvestmentAmgen
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M
Leadership Team
Recent News
2026-01-07
Company data provided by crunchbase